Celadon Pharmaceuticals PLC (GB:CEL) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Celadon Pharmaceuticals PLC has bolstered its financial position by receiving £150,000 from a recent subscription of shares, highlighting its commitment to advancing cannabis-based medicines in the UK. The company is focused on improving the quality of life for chronic pain sufferers and expanding its intellectual property in the pharmaceutical cannabis market.
For further insights into GB:CEL stock, check out TipRanks’ Stock Analysis page.